Advertisement
Person › Details
Evelina Vågesjö (Ilya Pharma AB)
Vågesjö, Evelina (Ilya Pharma 201809 CEO + Co-Founder)
Organisation | Ilya Pharma AB | |
Product | ILP-100 (Ilya Pharma) | |
Product 2 | immunotherapy | |
Source | Nordic Lifescience [Otmani, Malin]. (3/17/22). "News: Ilya Pharma Closes 8.5 Million EUR Funding Round". | |
Record changed: 2022-04-04 |
Advertisement
More documents for Evelina Vågesjö
- [1] Nordic Lifescience [Otmani, Malin]. (3/17/22). "News: Ilya Pharma Closes 8.5 Million EUR Funding Round"....
- [2] Ilya Pharma AB. (9/10/18). "Press Release: Ilya Pharma Raises Additional Euro 3 Million to Take Novel ATMP through to Phase II for Wound Care"....
- [3] Ilya Pharma AB. (11/30/17). "Press Release: Ilya Pharma Is Awarded Three Million Euros from H2020 EU SME Programme"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top